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Background: The relation between obesity and respiratory function is complex and may be
confounded by other components of body habitus such as lean muscle mass. The present study
aimed to explore the association between two different measures of body habitus (Body Mass
Index e BMI, and lean muscle mass) with lung function.
Methods: We used data from 2663 adults who participated in a community-based survey and
provided measures of lung function, BMI and 24-h urinary creatinine excretion to quantify lean
muscle mass.
Results: There was a positive linear association between 24-h urinary creatinine excretion and
lung function as measured by both Forced Expiratory Volume in 1 s (FEV1) and Forced Vital
Capacity. A one standard deviation increment in 24-h urinary creatinine excretion was associ-
ated with a 45 ml increase in FEV1 (95% confidence intervals CI: þ16 to þ73). There was no
linear association between body mass index and lung function although those in the extreme
categories of BMI had lower measures of lung function compared to a reference group with
a BMI of 20e24.9 kg/m2. For FEV1, BMI less than 20 kg/m
2 was 122 ml lower (95% CI: 234
to 10); BMI greater than 30 kg/m2 was 85 ml lower (95% CI: 160 to 9).
Conclusions: Lean muscle mass and BMI have very different associations with lung function
that have implications for understanding the relationship between body habitus and lung
function.
ª 2011 Elsevier Ltd. All rights reserved.15 8231715; fax: þ44 115 8231946.
ottingham.ac.uk (A.W. Fogarty).
1 Elsevier Ltd. All rights reserved.
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Obesity is an increasingly important public health challenge
which impacts on a variety of respiratory diseases.1e3 A
commonly used epidemiological measure of obesity is body
mass index (BMI) which is easily measured in large pop-
ulations. However, the cross-sectional evidence on the
association between obesity as measured by BMI and lung
function is complex, probably partly as a consequence of
the observation of data from heterogeneous populations. A
review stated that there is an inverse relationship between
body mass index and FEV1,
4 and other investigators have
reported an inverted U shaped relation between these
variables using population-based data.5 A recent study
reported that in individuals with a BMI less than 25 kg/m2,
FEV1 is positively associated with BMI
6 and the authors
speculated that this may be a consequence of confounding
by muscle mass, a variable that may account for the
differing associations reported between BMI and lung
function in other study populations. Bone-free lean muscle
mass is positively associated with lung function7 and Forced
Vital Capacity (FVC) is positively associated with fat free
mass as measured by skinfold thickness measurements and
also with measures of muscular strength.8 To date there
have been no population-based studies of measures of total
lean muscle mass and lung function.
Using 24-h urinary creatinine excretion, a simple vali-
dated biochemical marker of total skeletal muscle
mass,9e11 we have investigated the relation between total
body muscle mass and lung function using data from
a randomly selected population and compared this with the
associations between BMI and lung function.
Patients and methods
The participants are drawn from a previously reported
randomly selected community-based population of 2633
adults aged 18-70 living in Nottingham first studied in 1991
that had a participation rate of 48e59% eligible individ-
uals.12 The study was approved by the Nottingham City
Hospital Ethics Committee.
In 1991 participants were asked to abstain from inhaled
bronchodilators for 4 h and from oral bronchodilators for 8 h
before their study visit. Subjects completed a computer-
administered lifestyle questionnaire that included a semi-
quantitative dietary questionnaire (DietQ, Tinuviel Soft-
ware, Warrington, Cheshire, UK). Forced Expiratory Volume
in 1 s (FEV1) and Forced Vital Capacity (FVC) were then
measured using a dry bellows spirometer (Vitalograph,
Buckingham, UK), taking the best of three technically
satisfactory manoeuvres with the subject seated. Data were
collected on a variety of anthropometric measures including
height and weight, and a blood sample and 24-h urine
collections obtained from those who consented to provide
specimens. Written instructions were provided to optimise
the accuracy of the 24-h urine collection, and the self-report
of the participant used to verify the accuracy of 24-h urine
collection. If the self-report indicated that the urine sample
was sub-optimal, then the times of urine collection were
used to generate a corrected measure of 24-h urinary
creatinine collection. After venesection, serum sampleswere separated by centrifugation, within 15 min and stored
at 80 centigrade. The 24-h urinary creatinine excretion
was calculated by weighing returned specimens to estimate
volume, and an aliquot was separated and sent for estima-
tion of creatinine concentrations using a reaction rate assay
on an Olympus AU5000 analyser. Serum CRP was measured in
2005 using a highly sensitive automated immunoturbidi-
metric assay on an Olympus AU5400 analyser.
Smoking status was defined in three categories; current
smoker (those who had smoked within one month of the
study in 1991), ex-smoker and never smokers. The number
of pack-years smoked was estimated for subjects from their
reported age at starting smoking, and the usual amount
smoked during this period.
We analysed the cross-sectional association between both
24-h urinary creatinine excretion and BMI with lung function
using multiple linear regression with adjustment for a priori
confounding factors of age, sex, height, smoking status and
cigarette pack-years smoked. Linearity of the datawas tested
using the likelihood ratio test; if the association was linear,
the final model presented the exposure as a continuous vari-
able and if the association was non-linear a categorical vari-
able was used in analyses. As the associations between BMI
and lung function were non-linear, BMI was coded as a cate-
gorical variable (BMI<20 kg/m2, 20e24.9 kg/m2, 25e29.9 kg/
m2 and 30 kg/m2). Potential confounding factors including
vitamin C, magnesium, protein intake and serum C-reactive
protein were investigated by adding them to the a priori
model and if the size of effect changed by 10% or more they
were considered to be a potential confounding factor and
retained in the model. Similarly, the impact of adding age as
a categorical variable and higher order variables such as age
squared and height squared on the relationships observed
were also explored and retained if the size of effect changed
by 10% or more. As the association with lung function was
linear, the 24-h urinary creatinine excretion data are pre-
sented in terms of change in lung function per standard
deviation increase in 24-h urinary creatinine excretion. We
used the same model established for 24-h creatinine excre-
tion to explore the association of BMI with both FEV1 and FVC
independently, modelling BMI as a categorical variable. The
association of both 24-h urinary creatinine excretion and BMI
with lung function is presented with and without adjustment
for the alternative measure of body habitus. Effect modifi-
cation by gender as defined by an interactive term with a p-
value of 0.10 or less was explored and absent, so the data are
presented for the complete study population. The analyses
were carried out using STATA version 11 (Stata Corporation,
College Station, Texas).Results
Of the 2633 individuals who participated in the study, 2614
(99%) provided data on BMI, and 1702 (65%) provided 24-h
urinary samples. The mean age of those who participated
was 44.4 years (standard deviation sd, 13.6), 50% were male
and 23% were current smokers (Table 1). The mean 24-h
urine volume was 2.13 L (sd 0.76) and the mean uncor-
rected 24-h urinary creatinine excretion was 13.52 mmol/
day (sd 4.25) and the mean corrected 24-h urinary creati-
nine excretion was 13.88 mmol/day (sd 4.48). Those who
Table 1 Baseline Characteristics of Study Population.
Total study
population
Provided 24-h
urine sample
Did not provide
24-h urine sample
Number of participants 2633 1702 931
Males N (%) 1312 (50%) 849 (50%) 463 (50%)
Age mean in yrs (sd) 44.4 (13.6) 46.4 (12.8) 40.7 (14.3)
Mean height m (sd) 1.68 (0.10) 1.68 (0.10) 1.69 (0.10)
Mean body mass index kg/m2 (sd) 25.5 (4.0)
N Z 2614
25.5 (3.9)
N Z 1687
25.5 (4.3)
N Z 927
Smoking status N (%)
Never 1306 (50) 873 (51) 433 (47)
Ex 730 (28) 492 (29) 238 (26)
Current 597 (23) 337 (20) 260 (28)
FEV1 e L (sd) 3.19 (0.9) 3.20 (0.85) 3.16 (1.03)
FVC e L (sd) 3.94 (1.1) 3.96 (1.02) 3.91 (1.15)
Median CRP (mg/l) 1.14 1.10 1.24
IQR (0.55e2.42)
N Z 2442
(0.55e2.20)
N Z 1597
(0.55e3.19)
N Z 845
Urine volume L, (sd) 2.1 (0.8)
Mean uncorrected 24-h urinary
creatinine excretion, mmol/day (sd)
e 13.45 (4.25) e
Mean corrected 24-h urinary
creatinine excretion, mmol/day (sd)
e 13.88 (4.48) e
FEV1 Z Forced Expiratory Volume in 1 s.
FVC Z Forced Vital Capacity.
CRP Z C-reactive protein.
IQR Z interquartile range.
sd Z standard deviation.
1898 A.W. Fogarty et al.provided 24-h urinary samples were older and had a lower
prevalence of current cigarette smoking than those who did
not provide a urinary sample (Table 1).
There was a linear association between FEV1 and
uncorrected 24-h urinary creatinine excretion, with a stan-
dard deviation increment in 24-h urinary creatinine excre-
tion being associated with an increase of 45 ml (95%
confidence intervals CI: þ16 to þ73) after adjusting for sex,
age, height, smoking status and smoking pack-years. Similar
associations were also seen between Forced Vital Capacity
and 24-h urinary excretion, with a standard deviation
increment in 24-h urinary creatinine excretion being asso-
ciated with an increase of 39 ml (95% confidence intervals
CI: þ4 to þ75) after adjusting for the same covariates. The
size of association observed increased after adjustment for
BMI as a covariate (Table 2). Repeating analyses using the
24-h urinary creatinine data corrected for sample collec-
tion irregularities made no appreciable difference to these
associations. No association was observed between 24-h
urinary creatinine excretion and the FEV1:FVC ratio.
The associations between FEV1 and FVC and BMI were
non-linear and are presented in categories in Table 2 for
the total study population and also stratified by gender as
the association between body mass index and FEV1
(p Z 0.08) and FVC (p < 0.01) did demonstrate some
evidence of an interaction with gender. Using a BMI of 20 up
to 24.9 kg/m2 as a reference group, those with a BMI of less
than 20 kg/m2 had a lower lung function with values of
169 ml (95% CI: 266 to 72) and 224 ml (95% CI: 336
to 114) for FEV1 and FVC respectively. Those with a BMI ofequal to or greater than 30 kg/m2 had a significantly
reduced FVC compared to the reference category (130 ml,
95% CI: 206 to 54), but no significant decrease in FEV1
(48 ml, 95% CI: 114 to þ19). These associations were
appreciably altered after adjustment for 24-h urinary
creatinine excretion with a decreased size of association
with lung function for those with a BMI less than 20 kg/m2
and an increased size of association for those with a BMI
greater than 25 kg/m2 (Table 2). There was a linear asso-
ciation between BMI and the FEV1:FVC ratio, with a one unit
increase in BMI being associated with a decrease of 0.16%
(95% CI: 0.09e0.24).
There was no confounding of these associations by
intake of protein, vitamin C or magnesium or by serum C-
reactive protein levels. There was no effect modification of
the associations between lung function and 24-h urinary
creatinine excretion by gender, but the association
between body mass index and FEV1 (p Z 0.08) and FVC
(p < 0.01) did demonstrate some evidence of an interaction
with gender.Discussion
In this study, we report for the first time that 24-h urinary
creatinine excretion is associated with higher FEV1 and FVC
cross-sectionally, in a randomly selected population after
adjusting for confounding factors including BMI. This
observation supports the hypothesis that total lean muscle
mass is positively associated with lung function and is
Table 2 The Cross-sectional Association between Two Measures of Body Habitus (24-h Urinary Creatinine Excretion and Body
Mass Index) and Forced Expiratory Volume in 1 s and Forced Vital Capacity.
FEV1 (ml) FVC (ml)
Model A
(95% CI)
Model A þ BMI
(95% CI)
Model A
(95% CI)
Model A þ BMI
(95% CI)
24-h urinary creatinine
excretion
(per sd increment in
mmol/day)
þ45
(þ16 to þ73)
þ52
(þ21 to þ82)
þ39
(þ4 to þ75)
þ62
(þ25 to þ99)
Males þ24
(15 to þ63)
þ35
(8 to þ77)
þ11
(35 to þ59þ
þ45
(3 to þ101)
Females þ91
(þ48 to þ134)
þ102
(þ57 to þ147)
þ104
(þ51 to þ156)
þ124
(þ69 to þ178)
Model A
(95% CI)
Model A þ 24-h urinary
creatinine excretion
(95% CI)
Model A
(95% CI)
Model A þ 24-h urinary
creatinine excretion
(95% CI)
Body Mass Index
(kg/m2) <20
169
(266 to 73)
122
(234 to 10)
225
(336 to 114)
155
(292 to 17)
Males 91
(300 to þ117)
þ9
(203 to þ221)
111
(347 to þ126)
þ2
(259 to þ264)
Females 166
(255 to 77)
156
(272 to 40)
234
(339 to 129)
192
(333 to 51)
20e24.9
(reference)
e e e e
25e29.9 0
(46 to þ46)
37
(86 to þ12)
41
(93 to þ11)
97
(157 to 37)
Males þ36
(37 to þ110)
10
(88 to þ68)
23
(107 to þ60)
111
(148 to 71)
Females 39
(90 to þ12)
55
(113 to þ2)
60
(120 to 0)
77
(148 to 7)
30þ 48
(114 to þ19)
85
(160 to 9)
130
(206 to 54)
200
(292 to 108)
Males 35
(149 to þ79)
50
(179 to þ79)
136
(265 to 6)
235
(394 to 76)
Females 79
(149 to 10)
137
(220 to 54)
148
(230 to 66)
204
(305 to 104)
Model A adjusted for sex, age, height, smoking status (current, ex, never) and pack-years smoked.
FEV1 e Forced Expiratory Volume in 1 s.
FVC e forced Vital Capacity.
BMI e body mass index.
sd e standard deviation.
There was no effect modification of the associations between lung function and 24-h urinary creatinine excretion by gender, but the
association between body mass index and FEV1 (p Z 0.08) and FVC (p < 0.01) did demonstrate some evidence of an interaction with
gender.
Body habitus and lung function 1899a potential confounding factor in the association observed
between obesity and lung function. There was no compa-
rable linear association with BMI, although those with a low
BMI had lower FEV1 and FVC and those with a high BMI had
a lower FVC compared to the reference group.
The population studied was a random sample from the
electoral register of a Local Authority Area in Nottingham,
and is thus likely to be a representative sample of the
general population. The physiological measurements of
lung function and the biological samples were collected in
a standardised manner, and neither participants nor those
involved in the data collection were aware of the hypoth-
esis being tested. We were able to adjust for protein,vitamin C and magnesium intake and serum CRP as markers
of nutritional depletion and systemic inflammation, both of
which are considered possible causes of the skeletal muscle
dysfunction observed in COPD.13 However, we are unable to
exclude the possibility that the measurement error in the
dietary measurements by food frequency questionnaires
may have resulted in an incomplete adjustment for these
dietary constituents.
There has been much interest in the association between
body habitus and lung function as this provides an insight into
the potential impact of developmental and environmental
factors on lung function and hence may increase under-
standing of reversible factors amenable to interventions that
1900 A.W. Fogarty et al.aim to optimise lung function. The availability of data on
urinary creatinine excretion provides an opportunity to
assess the association between lean muscle mass and lung
function in a large epidemiological study, and to compare
this with BMI, which is regularly used as a measure of body
habitus in population-based studies. Creatine in muscle
gradually degrades to creatinine, which is then excreted in
the urine, and the excretion rate of creatinine is considered
to be proportional to total lean body mass. This measure has
been validated against a variety of non-radiological
measures of lean muscle mass with correlation coefficients
that vary from 0.63 to 0.99,14e17 and also in studies which
used radiological imaging techniques to quantify leanmuscle
mass, and these latter studies reported correlation coeffi-
cients of 0.80e0.92.9e11 We conclude that 24-h urinary
creatinine excretion is thus probably one of the best avail-
able methods to rank total lean body mass in large epide-
miological studies without exposing individuals to
unnecessary radiation. In addition, 24-h urinary excretion
has been reported to have good repeatability with a coeffi-
cient of variation of 9.3%.18 Other factors in addition to total
body muscle mass may also influence 24-h urinary creatinine
excretion, particularly age, gender,19 protein intake20 and
renal function.21 Althoughwewere able to adjust for the first
three factors as part of the analysis, we are unable to
exclude the possibility that renal function may be an unad-
justed confounding factor in our analysis as we did not
measure our study participants’ renal function. However,
this seems unlikely as our population had a mean age of 46
years, and hence we would anticipate that impaired renal
function would have a low prevalence that is probably no
higher than 7%22 and hence unlikely to confound our
observations.
Our cross-sectional data do not permit temporal rela-
tionships to be considered, and therefore it is possible that
higher lung function may lead to an elevated total muscle
mass possibly by increasing the ability to exercise. This is
certainly plausible as both lung function and the body
musculature both develop in parallel during childhood and
adolescence. The biological mechanisms that underpin
these observations that total muscle mass is positively
associated with lung function are poorly understood.
Possible candidate explanations include the role of inter-
costal muscles23,24 or the diaphragm25,26 in developing and
maintaining lung function, or early nutrition and growth
which has consistently been associated with higher lung
function.27 Chronic respiratory diseases,28 and in particular
COPD are associated with reduced muscle mass and
strength13,29e31 when the primary insult is to the lungs and
hence the reduced muscle bulk and function are likely to be
a secondary phenomenon.32,33
Our data are consistent with other large cross-sectional
studies of the association between body mass index and
lung function. Data from the Third National Health and
Nutrition Examination Survey similarly demonstrated that
the graphed relationship between BMI quintiles and both
FEV1 and FVC is an inverted U shape,
5 suggesting that
extremes of body mass index are associated with lower lung
function. A similar inverted U shaped association between
BMI and FEV1 was also reported from a cross-sectional study
of 2153 adults living in Western New York State, with
a linear inverse association observed between BMI andFVC.34 Our data is consistent with the observation that in
individuals with a BMI less than 25 kg/m2, FEV1 is positively
associated with BMI6 as this may be a consequence of
confounding by muscle mass in adults who are not
overweight.
In summary, we report the positive linear association
between total lean muscle mass and lung function and non-
linear associations between BMI and lung function in
a population-based study of adults. These observations may
be of relevance to further understanding the complex
associations between measures of body habitus and lung
function which represent the cumulative effects of
multiple exposures over the course of a lifetime.
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